nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0519	0.0652	CbGbCtD
Sulfadiazine—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0512	0.0643	CbGbCtD
Sulfadiazine—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0512	0.0643	CbGbCtD
Sulfadiazine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.042	0.0527	CbGbCtD
Sulfadiazine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0395	0.0496	CbGbCtD
Sulfadiazine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0395	0.0496	CbGbCtD
Sulfadiazine—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0388	0.0487	CbGbCtD
Sulfadiazine—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0388	0.0487	CbGbCtD
Sulfadiazine—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0372	0.0467	CbGbCtD
Sulfadiazine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0357	0.0448	CbGbCtD
Sulfadiazine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0357	0.0448	CbGbCtD
Sulfadiazine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0308	0.0387	CbGbCtD
Sulfadiazine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0299	0.0376	CbGbCtD
Sulfadiazine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.027	0.034	CbGbCtD
Sulfadiazine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.027	0.034	CbGbCtD
Sulfadiazine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0259	0.0326	CbGbCtD
Sulfadiazine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0244	0.0307	CbGbCtD
Sulfadiazine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0229	0.0288	CbGbCtD
Sulfadiazine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0229	0.0288	CbGbCtD
Sulfadiazine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0208	0.0261	CbGbCtD
Sulfadiazine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0208	0.0261	CbGbCtD
Sulfadiazine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0179	0.0225	CbGbCtD
Sulfadiazine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0174	0.0219	CbGbCtD
Sulfadiazine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0157	0.0198	CbGbCtD
Sulfadiazine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0157	0.0198	CbGbCtD
Sulfadiazine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0151	0.0189	CbGbCtD
Sulfadiazine—Sulfamethazine—ALB—acquired immunodeficiency syndrome	0.000741	0.316	CrCbGaD
Sulfadiazine—Sulfamerazine—ALB—acquired immunodeficiency syndrome	0.000725	0.309	CrCbGaD
Sulfadiazine—Sulfamethizole—ALB—acquired immunodeficiency syndrome	0.000562	0.24	CrCbGaD
Sulfadiazine—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000437	0.00216	CcSEcCtD
Sulfadiazine—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000436	0.00216	CcSEcCtD
Sulfadiazine—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.000436	0.00216	CcSEcCtD
Sulfadiazine—Stomatitis—Lamivudine—acquired immunodeficiency syndrome	0.000434	0.00215	CcSEcCtD
Sulfadiazine—Hallucination—Ritonavir—acquired immunodeficiency syndrome	0.000433	0.00215	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000432	0.00214	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000431	0.00214	CcSEcCtD
Sulfadiazine—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.00043	0.00213	CcSEcCtD
Sulfadiazine—Chills—Delavirdine—acquired immunodeficiency syndrome	0.000423	0.00209	CcSEcCtD
Sulfadiazine—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.000423	0.00209	CcSEcCtD
Sulfadiazine—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.000419	0.00208	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000418	0.00207	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.000417	0.00207	CcSEcCtD
Sulfadiazine—Hallucination—Saquinavir—acquired immunodeficiency syndrome	0.000417	0.00207	CcSEcCtD
Sulfadiazine—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000417	0.00206	CcSEcCtD
Sulfadiazine—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000417	0.00206	CcSEcCtD
Sulfadiazine—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000416	0.00206	CcSEcCtD
Sulfadiazine—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.000415	0.00206	CcSEcCtD
Sulfadiazine—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.000415	0.00206	CcSEcCtD
Sulfadiazine—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.000414	0.00205	CcSEcCtD
Sulfadiazine—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000412	0.00204	CcSEcCtD
Sulfadiazine—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000412	0.00204	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000411	0.00204	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000409	0.00203	CcSEcCtD
Sulfadiazine—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000409	0.00203	CcSEcCtD
Sulfadiazine—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000408	0.00202	CcSEcCtD
Sulfadiazine—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000407	0.00202	CcSEcCtD
Sulfadiazine—Tinnitus—Ritonavir—acquired immunodeficiency syndrome	0.000406	0.00201	CcSEcCtD
Sulfadiazine—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.0004	0.00198	CcSEcCtD
Sulfadiazine—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000399	0.00198	CcSEcCtD
Sulfadiazine—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000398	0.00197	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000398	0.00197	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000397	0.00196	CcSEcCtD
Sulfadiazine—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000396	0.00196	CcSEcCtD
Sulfadiazine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000396	0.00196	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000395	0.00196	CcSEcCtD
Sulfadiazine—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000392	0.00194	CcSEcCtD
Sulfadiazine—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.000391	0.00194	CcSEcCtD
Sulfadiazine—Chills—Ritonavir—acquired immunodeficiency syndrome	0.000391	0.00194	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00039	0.00193	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000389	0.00193	CcSEcCtD
Sulfadiazine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000389	0.00192	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000388	0.00192	CcSEcCtD
Sulfadiazine—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000386	0.00191	CcSEcCtD
Sulfadiazine—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000385	0.00191	CcSEcCtD
Sulfadiazine—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000379	0.00188	CcSEcCtD
Sulfadiazine—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000378	0.00187	CcSEcCtD
Sulfadiazine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000377	0.00187	CcSEcCtD
Sulfadiazine—Chills—Saquinavir—acquired immunodeficiency syndrome	0.000376	0.00186	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000376	0.00186	CcSEcCtD
Sulfadiazine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000375	0.00186	CcSEcCtD
Sulfadiazine—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000375	0.00186	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000374	0.00185	CcSEcCtD
Sulfadiazine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000373	0.00185	CcSEcCtD
Sulfadiazine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000371	0.00184	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00037	0.00183	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000369	0.00183	CcSEcCtD
Sulfadiazine—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000368	0.00182	CcSEcCtD
Sulfadiazine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000368	0.00182	CcSEcCtD
Sulfadiazine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000367	0.00182	CcSEcCtD
Sulfadiazine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000365	0.00181	CcSEcCtD
Sulfadiazine—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000365	0.00181	CcSEcCtD
Sulfadiazine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000365	0.00181	CcSEcCtD
Sulfadiazine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000364	0.0018	CcSEcCtD
Sulfadiazine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000364	0.0018	CcSEcCtD
Sulfadiazine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000363	0.0018	CcSEcCtD
Sulfadiazine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000363	0.0018	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000363	0.0018	CcSEcCtD
Sulfadiazine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000362	0.00179	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000362	0.00179	CcSEcCtD
Sulfadiazine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000362	0.00179	CcSEcCtD
Sulfadiazine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000362	0.00179	CcSEcCtD
Sulfadiazine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000361	0.00179	CcSEcCtD
Sulfadiazine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00036	0.00178	CcSEcCtD
Sulfadiazine—Chills—Lamivudine—acquired immunodeficiency syndrome	0.000359	0.00178	CcSEcCtD
Sulfadiazine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000358	0.00177	CcSEcCtD
Sulfadiazine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000357	0.00177	CcSEcCtD
Sulfadiazine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000357	0.00177	CcSEcCtD
Sulfadiazine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000353	0.00175	CcSEcCtD
Sulfadiazine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000349	0.00173	CcSEcCtD
Sulfadiazine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000349	0.00173	CcSEcCtD
Sulfadiazine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000346	0.00171	CcSEcCtD
Sulfadiazine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000344	0.0017	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000344	0.0017	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000342	0.0017	CcSEcCtD
Sulfadiazine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000341	0.00169	CcSEcCtD
Sulfadiazine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.00168	CcSEcCtD
Sulfadiazine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000338	0.00168	CcSEcCtD
Sulfadiazine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000337	0.00167	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000337	0.00167	CcSEcCtD
Sulfadiazine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000336	0.00166	CcSEcCtD
Sulfadiazine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000335	0.00166	CcSEcCtD
Sulfadiazine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000335	0.00166	CcSEcCtD
Sulfadiazine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000333	0.00165	CcSEcCtD
Sulfadiazine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000333	0.00165	CcSEcCtD
Sulfadiazine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000332	0.00165	CcSEcCtD
Sulfadiazine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000332	0.00165	CcSEcCtD
Sulfadiazine—Headache—Didanosine—acquired immunodeficiency syndrome	0.00033	0.00164	CcSEcCtD
Sulfadiazine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000328	0.00163	CcSEcCtD
Sulfadiazine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000328	0.00162	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000328	0.00162	CcSEcCtD
Sulfadiazine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000327	0.00162	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000325	0.00161	CcSEcCtD
Sulfadiazine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000325	0.00161	CcSEcCtD
Sulfadiazine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000324	0.00161	CcSEcCtD
Sulfadiazine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000324	0.0016	CcSEcCtD
Sulfadiazine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000323	0.0016	CcSEcCtD
Sulfadiazine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000322	0.00159	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00032	0.00158	CcSEcCtD
Sulfadiazine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000319	0.00158	CcSEcCtD
Sulfadiazine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000319	0.00158	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000319	0.00158	CcSEcCtD
Sulfadiazine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000316	0.00157	CcSEcCtD
Sulfadiazine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000316	0.00157	CcSEcCtD
Sulfadiazine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000316	0.00157	CcSEcCtD
Sulfadiazine—Sulfamethoxazole—ALB—acquired immunodeficiency syndrome	0.000315	0.135	CrCbGaD
Sulfadiazine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000315	0.00156	CcSEcCtD
Sulfadiazine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000315	0.00156	CcSEcCtD
Sulfadiazine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000314	0.00156	CcSEcCtD
Sulfadiazine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000313	0.00155	CcSEcCtD
Sulfadiazine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000313	0.00155	CcSEcCtD
Sulfadiazine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000313	0.00155	CcSEcCtD
Sulfadiazine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000312	0.00154	CcSEcCtD
Sulfadiazine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000311	0.00154	CcSEcCtD
Sulfadiazine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000309	0.00153	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000305	0.00151	CcSEcCtD
Sulfadiazine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000304	0.00151	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000303	0.0015	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000303	0.0015	CcSEcCtD
Sulfadiazine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000303	0.0015	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000302	0.00149	CcSEcCtD
Sulfadiazine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000302	0.00149	CcSEcCtD
Sulfadiazine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000302	0.00149	CcSEcCtD
Sulfadiazine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000299	0.00148	CcSEcCtD
Sulfadiazine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000299	0.00148	CcSEcCtD
Sulfadiazine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000297	0.00147	CcSEcCtD
Sulfadiazine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000296	0.00147	CcSEcCtD
Sulfadiazine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000295	0.00146	CcSEcCtD
Sulfadiazine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000294	0.00146	CcSEcCtD
Sulfadiazine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000293	0.00145	CcSEcCtD
Sulfadiazine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000293	0.00145	CcSEcCtD
Sulfadiazine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000292	0.00145	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000292	0.00144	CcSEcCtD
Sulfadiazine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000291	0.00144	CcSEcCtD
Sulfadiazine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000291	0.00144	CcSEcCtD
Sulfadiazine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00029	0.00143	CcSEcCtD
Sulfadiazine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000289	0.00143	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000289	0.00143	CcSEcCtD
Sulfadiazine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000289	0.00143	CcSEcCtD
Sulfadiazine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000288	0.00143	CcSEcCtD
Sulfadiazine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000288	0.00142	CcSEcCtD
Sulfadiazine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000287	0.00142	CcSEcCtD
Sulfadiazine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000287	0.00142	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000286	0.00142	CcSEcCtD
Sulfadiazine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000284	0.00141	CcSEcCtD
Sulfadiazine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000284	0.00141	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000284	0.00141	CcSEcCtD
Sulfadiazine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000284	0.00141	CcSEcCtD
Sulfadiazine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000283	0.0014	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000282	0.0014	CcSEcCtD
Sulfadiazine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000282	0.00139	CcSEcCtD
Sulfadiazine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000282	0.00139	CcSEcCtD
Sulfadiazine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00028	0.00139	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000278	0.00138	CcSEcCtD
Sulfadiazine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000278	0.00138	CcSEcCtD
Sulfadiazine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000276	0.00137	CcSEcCtD
Sulfadiazine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000276	0.00137	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000274	0.00135	CcSEcCtD
Sulfadiazine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000273	0.00135	CcSEcCtD
Sulfadiazine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000273	0.00135	CcSEcCtD
Sulfadiazine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000272	0.00135	CcSEcCtD
Sulfadiazine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000272	0.00135	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000271	0.00134	CcSEcCtD
Sulfadiazine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000271	0.00134	CcSEcCtD
Sulfadiazine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.00133	CcSEcCtD
Sulfadiazine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000269	0.00133	CcSEcCtD
Sulfadiazine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000268	0.00133	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000267	0.00132	CcSEcCtD
Sulfadiazine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000266	0.00132	CcSEcCtD
Sulfadiazine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000265	0.00131	CcSEcCtD
Sulfadiazine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000265	0.00131	CcSEcCtD
Sulfadiazine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000262	0.0013	CcSEcCtD
Sulfadiazine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000259	0.00128	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000259	0.00128	CcSEcCtD
Sulfadiazine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.00128	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.00127	CcSEcCtD
Sulfadiazine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.00127	CcSEcCtD
Sulfadiazine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000253	0.00125	CcSEcCtD
Sulfadiazine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000253	0.00125	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.00125	CcSEcCtD
Sulfadiazine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000251	0.00124	CcSEcCtD
Sulfadiazine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000251	0.00124	CcSEcCtD
Sulfadiazine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000249	0.00123	CcSEcCtD
Sulfadiazine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000247	0.00123	CcSEcCtD
Sulfadiazine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000247	0.00122	CcSEcCtD
Sulfadiazine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.00122	CcSEcCtD
Sulfadiazine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000246	0.00122	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.00121	CcSEcCtD
Sulfadiazine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.00121	CcSEcCtD
Sulfadiazine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.00121	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000244	0.00121	CcSEcCtD
Sulfadiazine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.00118	CcSEcCtD
Sulfadiazine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000237	0.00117	CcSEcCtD
Sulfadiazine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.00117	CcSEcCtD
Sulfadiazine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000236	0.00117	CcSEcCtD
Sulfadiazine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000235	0.00117	CcSEcCtD
Sulfadiazine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000235	0.00117	CcSEcCtD
Sulfadiazine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000235	0.00117	CcSEcCtD
Sulfadiazine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000233	0.00116	CcSEcCtD
Sulfadiazine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000233	0.00115	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.00115	CcSEcCtD
Sulfadiazine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000232	0.00115	CcSEcCtD
Sulfadiazine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000229	0.00113	CcSEcCtD
Sulfadiazine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.00113	CcSEcCtD
Sulfadiazine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.00112	CcSEcCtD
Sulfadiazine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.00111	CcSEcCtD
Sulfadiazine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.00111	CcSEcCtD
Sulfadiazine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.0011	CcSEcCtD
Sulfadiazine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.00109	CcSEcCtD
Sulfadiazine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.00109	CcSEcCtD
Sulfadiazine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00022	0.00109	CcSEcCtD
Sulfadiazine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.00109	CcSEcCtD
Sulfadiazine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000219	0.00108	CcSEcCtD
Sulfadiazine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.00108	CcSEcCtD
Sulfadiazine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.00105	CcSEcCtD
Sulfadiazine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.00105	CcSEcCtD
Sulfadiazine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000211	0.00104	CcSEcCtD
Sulfadiazine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000211	0.00104	CcSEcCtD
Sulfadiazine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.00104	CcSEcCtD
Sulfadiazine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.00104	CcSEcCtD
Sulfadiazine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.00104	CcSEcCtD
Sulfadiazine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.00103	CcSEcCtD
Sulfadiazine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.00101	CcSEcCtD
Sulfadiazine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.000995	CcSEcCtD
Sulfadiazine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000984	CcSEcCtD
Sulfadiazine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000974	CcSEcCtD
Sulfadiazine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000966	CcSEcCtD
Sulfadiazine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000965	CcSEcCtD
Sulfadiazine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000963	CcSEcCtD
Sulfadiazine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.00096	CcSEcCtD
Sulfadiazine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000938	CcSEcCtD
Sulfadiazine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.00093	CcSEcCtD
Sulfadiazine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.000929	CcSEcCtD
Sulfadiazine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000924	CcSEcCtD
Sulfadiazine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.00091	CcSEcCtD
Sulfadiazine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000894	CcSEcCtD
Sulfadiazine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000887	CcSEcCtD
Sulfadiazine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000886	CcSEcCtD
Sulfadiazine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000881	CcSEcCtD
Sulfadiazine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000876	CcSEcCtD
Sulfadiazine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000836	CcSEcCtD
